Experiencia en vida real con terapias frente a COVID-19 leve-moderado en trasplantados renales:¿ Cómo tratar a partir de ahora a los pacientes con enfermedad …
• Luis Alberto Vigara: luisberbig@ gmail. com/https://orcid. org/0000-0001-6568-6160• María
Eugenia Rodriguez: mariae. rodriguez. mateos. sspa@ juntadeandalucia. es• Myriam Eady …
Eugenia Rodriguez: mariae. rodriguez. mateos. sspa@ juntadeandalucia. es• Myriam Eady …
Concerns Over Prediction of Kidney Discard and Nonrecovery
F Zheng, K Chen, W Niu - JAMA surgery, 2024 - jamanetwork.com
To the EditorSageshima et al1 have proven the feasibility of modeling structured and
unstructured data via machine learning (ML) and natural language processing (NLP) to …
unstructured data via machine learning (ML) and natural language processing (NLP) to …
Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?
M Alonso, F Villanego, LA Vigara… - Nefrología (English …, 2024 - revistanefrologia.com
In recent months, recommendations for the treatment of nonhospitalized patients with mild-
moderate COVID-19 and high risk of progression to severe disease included several …
moderate COVID-19 and high risk of progression to severe disease included several …